Korean Circulation Journal

  • 제42권9호
  • /
  • Pages.646-649
  • /
  • 2012
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

Acute Stent Thrombosis and Heparin Induced Thrombocytopenia in a Patient With ST-Segment Elevation Myocardial Infarction

  • Shin, Hong-Won (Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University College of Medicine) ;
  • Yoon, Hyuck-Jun (Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University College of Medicine) ;
  • Choi, Sang-Woong (Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University College of Medicine) ;
  • Bae, Han-Jun (Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University College of Medicine) ;
  • Sohn, Ji-Hyun (Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University College of Medicine) ;
  • Lee, Ho-Myung (Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University College of Medicine) ;
  • Cho, Hyun-Ok (Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University College of Medicine) ;
  • Cho, Yun-Kyeong (Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University College of Medicine) ;
  • Park, Hyoung-Seob (Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University College of Medicine) ;
  • Kim, Hyung-Seop (Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University College of Medicine) ;
  • Nam, Chang-Wook (Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University College of Medicine) ;
  • Hur, Seung-Ho (Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University College of Medicine) ;
  • Kim, Yoon-Nyun (Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University College of Medicine) ;
  • Kim, Kwon-Bae (Division of Cardiology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University College of Medicine)
  • 발행 : 2012.09.30
⟨ 이전 논문 다음 논문 ⟩

초록

Heparin is an essential drug in the treatment of acute coronary syndrome and it is used during percutaneous coronary intervention (PCI). Heparin-induced thrombocytopenia (HIT), albeit a serious complication of heparin therapy characterized by thrombocytopenia and high risk for venous and arterial thrombosis, has rarely been previously reported during PCI. We report a case of an acute stent thrombosis due to an unusual cause, HIT during primary PCI, in a patient with acute myocardial infarction.

키워드

참고문헌

  1. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-30. https://doi.org/10.1001/jama.293.17.2126
  2. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-9. https://doi.org/10.1056/NEJMoa067731
  3. Wenaweser P, Rey C, Eberli FR, et al. Stent thrombosis following baremetal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J 2005; 26:1180-7. https://doi.org/10.1093/eurheartj/ehi135
  4. Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus- eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 2005;45:995-8. https://doi.org/10.1016/j.jacc.2004.12.066
  5. King SB 3rd. 2009 update of the ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction and guidelines on percutaneous coronary intervention: what should we change in clinical practice? Pol Arch Med Wewn 2010;120:6-8.
  6. Gupta BK, Savage MP, Brest AN. Acute myocardial infarction during coronary angioplasty associated with heparin-induced thrombocytopenia. Cathet Cardiovasc Diagn 1995;35:42-6. https://doi.org/10.1002/ccd.1810350108
  7. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-- executive summary. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004;44: 671-719. https://doi.org/10.1016/j.jacc.2004.07.002
  8. Babuin L, Pengo V. Argatroban in the management of heparin-induced thrombocytopenia. Vasc Health Risk Manag 2010;6:813-9.
  9. Dasari TW, Pappy R, Hennebry TA. Acute stent thrombosis associated with heparin-induced thrombocytopenia and abciximab-induced profound thrombocytopenia. J Invasive Cardiol 2011;23:E5-8.
  10. Hussain F, Philipp R, Zieroth S. HITT and stent thrombosis: a "clinical" diagnosis not to be missed. Int J Cardiol 2009;133:e11-3. https://doi.org/10.1016/j.ijcard.2007.08.078
  11. Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 2003;121:535-55. https://doi.org/10.1046/j.1365-2141.2003.04334.x
  12. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention). Catheter Cardiovasc Interv 2006;67:87-112. https://doi.org/10.1002/ccd.20606
  13. Matsue H, Masai T, Yoshikawa Y, Kawamura M. Serious acute coronary thrombosis associated with heparin-induced thrombocytopenia in off-pump coronary artery bypass grafting. Interact Cardiovasc Thorac Surg 2010;11:188-90. https://doi.org/10.1510/icvts.2010.232983
  14. Brieger DB, Mak KH, Kottke-Marchant K, Topol EJ. Heparin-induced thrombocytopenia. J Am Coll Cardiol 1998;31:1449-59. https://doi.org/10.1016/S0735-1097(98)00134-X
  15. Lewis BE, Matthai WH Jr, Cohen M, Moses JW, Hursting MJ, Leya F. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Catheter Cardiovasc Interv 2002;57:177-84. https://doi.org/10.1002/ccd.10276
  16. Rossig L, Genth-Zotz S, Rau M, et al. Argatroban for elective percutaneous coronary intervention: the ARG-E04 multi-center study. Int J Cardiol 2011;148:214-9. https://doi.org/10.1016/j.ijcard.2010.02.044
  17. Van Werkum JW, Heestermans AA, Zomer AC, et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol 2009;53:1399-409. https://doi.org/10.1016/j.jacc.2008.12.055

피인용 문헌

  1. Case Report: Concomitant coronary stent and femoral artery thrombosis in the setting of heparin-induced thrombocytopenia vol.8, pp.None, 2012, https://doi.org/10.12688/f1000research.19041.1